First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Clinical trial NCT05875168 · RECRUITING
Trial details
- NCT number
- NCT05875168
- Sponsor
- Daiichi Sankyo
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-18
- Primary completion
- 2026-10-20
- Enrollment
- 590
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.